UBS Group’s AMN Healthcare AMN Stock Holding History

UBS Group’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,900	Closed	-$198K	–	10266
2022 Q1	$198K	Buy	+1,900	New	+$197K	﹤0.01%	5378

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group's AMN Position: Q2 2026 in Review

UBS Group reduced its AMN Healthcare (AMN) stake by 26% in Q2 2026, selling an estimated $5.71M and leaving 646,553 shares worth $20.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2632.

UBS Group first reported a position in AMN in Q4 2014 and has held it in 47 quarters since. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

UBS Group held 646,553 shares of AMN Healthcare worth $20.9M as of Q2 2026.
UBS Group sold 221,423 AMN Healthcare shares in Q2 2026, an estimated $5.71M.
AMN Healthcare made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2632 holding.
UBS Group first reported a position in AMN Healthcare in Q4 2014 and has held it in 47 quarters since.
285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.